Publications
Below is a list of research publications published in scientific journals by IDDO and WWARN and our research partners. Use the filters to explore the publications by research theme or by using our list of key words. If you cannot find a publication, please email info@iddo.org
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
Zhu, L., van der Pluijm, R., Kucharski, M., Nayak, S., Tripathi, J., White, N., Day, N., Faiz, A., Phyo, A., Amaratunga, C., Lek, D., Ashley, E., Nosten, F., Smithuis, F., Ginsburg, H., von Seidlein, L., Lin, K., Imwong, M., Chotivanich, K., … Bozdech, Z. (2022). Communications Biology, 5.
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis
Dahal, P., Simpson, J., Abdulla, S., Ashley, E., Carrara, V., Fanello, C., Hien, H., & Price, R. (2022). Malaria Journal, 21.
Out of the boxes, out of the silos: The need of interdisciplinary collaboration to reduce poor-quality medical products in the supply chain
Masini, T., Macé, C., Heide, L., Hamill, H., Hampshire, K., Newton, P., & Ravinetto, R. (2022). Research in Social and Administrative Pharmacy, 18(9), 3694-3698.
Molecular surveillance for operationally relevant genetic polymorphisms in Plasmodium falciparum in Southern Chad, 2016–2017
Das, S., Kérah-Hinzoumbé, C., Kebféné, M., Srisutham, S., Nagorngar, T.-Y., Saralamba, N., Vongpromek, R., Khomvarn, T., Sibley, C., Guérin, P., Imwong, M., & Dhorda, M. (2022). Malaria Journal, 21(1).
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
Takashita, E., Kinoshita, N., Yamayoshi, S., Sakai-Tagawa, Y., Fujisaki, S., Ito, M., Iwatsuki-Horimoto, K., Chiba, S., Halfmann, P., Nagai, H., Saito, M., Adachi, E., Sullivan, D., Pekosz, A., Watanabe, S., Maeda, K., Imai, M., Yotsuyanagi, H., Mitsuya, H., … Kawaoka, Y. (2022). New England Journal of Medicine, 386(10), 995-998.
Zoonotic pathogens in wildlife traded in markets for human consumption, Laos
Nawtaisong, P., Robinson, M., Khammavong, K., Milavong, P., Rachlin, A., Dittrich, S., Dubot-Pérès, A., Vongsouvath, M., Horwood, P., Dussart, P., Theppangna, W., Douangngeum, B., Fine, A., Pruvot, M., & Newton, P. (2022). Emerging Infectious Diseases, 28(4), 860-864.
Flavivirus cross-reactivity would explain the apparent findings of Japanese encephalitis virus infection in Nigeria
Bharucha, T., Zitzmann, N., Newton, P., Dubot-Pérès, A., & Turtle, L. (2022). Journal of Immunoassay and Immunochemistry, 43(4), 463-465.
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data
(2022). BMC Medicine, 20(1).
Correlation analysis between gut microbiota alterations and the cytokine response in patients with coronavirus disease during hospitalization
Mizutani, T., Ishizaka, A., Koga, M., Ikeuchi, K., Saito, M., Adachi, E., Yamayoshi, S., Iwatsuki-Horimoto, K., Yasuhara, A., Kiyono, H., Matano, T., Suzuki, Y., Tsutsumi, T., Kawaoka, Y., & Yotsuyanagi, H. (2022). Microbiology Spectrum, 10(2).
Predictors associated with a better response to the Japanese aluminum‐free hepatitis A vaccine, Aimmugen®, for people living with HIV
Koga, M., Senkoji, T., Kubota, M., Ishizaka, A., Mizutani, T., Sedohara, A., Ikeuchi, K., Kikuchi, T., Adachi, E., Saito, M., Koibuchi, T., Hosomichi, K., Ohashi, J., Kawana‐Tachikawa, A., Matano, T., Tsutsumi, T., & Yotsuyanagi, H. (2022). Hepatology Research, 52(3), 227-234.
Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017–2020: a multicenter, retrospective cohort study in Japan
Taniguchi, Y., Kuno, T., Komiyama, J., Adomi, M., Suzuki, T., Abe, T., Ishimaru, M., Miyawaki, A., Saito, M., Ohbe, H., Miyamoto, Y., Imai, S., Kamio, T., Tamiya, N., & Iwagami, M. (2022). The Lancet Regional Health - Western Pacific, 20, 100365.
Urine collection devices to reduce contamination in urine samples for diagnosis of uncomplicated UTI: a single-blind randomised controlled trial in primary care
Hayward, G., Mort, S., Yu, L.-M., Voysey, M., Glogowska, M., Croxson, C., Yang, Y., Allen, J., Cook, J., Tearne, S., Blakey, N., Tonner, S., Sharma, V., Patil, M., Kelly, S., & Butler, C. (2022). British Journal of General Practice, 72(716), e225 - e33.
Protocol: Child and adolescent mental health and psychosocial support interventions: an evidence and gap map of low- and middle-income countries
Sharma, M., Perera, C., Ipince, A., Bakrania, S., Shokraneh, F., Idele, P., Anthony, D., & Banati, P. (2022). Campbell Systematic Reviews, 18(1).
Mechanism-based traps enable protease and hydrolase substrate discovery
Tang, S., Beattie, A., Kafkova, L., Petris, G., Huguenin-Dezot, N., Fiedler, M., Freeman, M., & Chin, J. (2022). Nature, 602, 701-707.
A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
Tabernero, P., Swamidoss, I., Mayxay, M., Khanthavong, M., Phonlavong, C., Vilayhong, C., Sichanh, C., Sengaloundeth, S., Green, M., & Newton, P. (2022). Journal of Antimicrobial Chemotherapy, 77(6), 1770-1778.
High Burden of Adverse Drug Reactions to Isoniazid Preventive Therapy in People Living With HIV at 3 Tertiary Hospitals in Uganda: Associated Factors
Nanyonga, S., Kitutu, F., Kalyango, J., Frank, M., & Kiguba, R. (2022). JAIDS Journal of Acquired Immune Deficiency Syndromes, 89(2), 215-221.
Aggregation and Transformation of Vector-Valued Messages in the Shuffle
Model of Differential Privacy
Scott, M., Cormode, G., & Maple, C. (2022).
Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials
White, N., Watson, J., & Baird, J. (2022). British Journal of Clinical Pharmacology, 88(6), 2657-2664.
Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis
Kagoro, F., Barnes, K., Marsh, K., Ekapirat, N., Mercado, C., Sinha, I., Humphreys, G., Dhorda, M., Guerin, P., & Maude, R. (2022). The Lancet Microbe, 3(3), e184 - e192.
The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions
McLean, A., Rashan, S., Tran, L., Arena, L., Lawal, A., Maguire, B., Adele, S., Antonio, E., Brack, M., Caldwell, F., Carrara, V., Charles, R., Citarella, B., Epie, T., Feteh, V., Kennon, K., Makuka, G., Ngu, R., Nwosu, A.-P., … Guérin, P. (2022). In Wellcome Open Research.
A case-control study of the causes of acute respiratory infection among hospitalized patients in Northeastern Laos
Phommasone, K., Xaiyaphet, X., Garcia-Rivera, J., Hontz, R., Pathavongsa, V., Keomoukda, P., Vongsouvath, M., Mayxay, M., Vongsouvath, M., Newton, P., Ashley, E., & Dubot-Pérès, A. (2022). Scientific Reports, 12.
Clinical impact of vivax malaria: a collection review
Phyo, A., Dahal, P., Mayxay, M., & Ashley, E. (2022). PLoS Medicine, 19.
Improving anthelmintic treatment for schistosomiasis and soil-transmitted helminthiases through sharing and reuse of individual participant data
Walker, M., Freitas, L., Halder, J., Brack, M., Keiser, J., King, C., Levecke, B., Lim, Y.-L., Pieri, O., Sow, D., Stothard, J., Webster, J., Zhou, X.-N., Terry, R., Guérin, P., & Basáñez, M.-G. (2022). Wellcome Open Research, 7, 5.
Risk of Plasmodium vivax recurrences follows a 30-70 rule and indicates relapse heterogeneity in the population
Stadler, E., Cromer, D., Mehra, S., Adekunle, A., Flegg, J., Anstey, N., Watson, J., Chu, C., Mueller, I., Robinson, L., Schlub, T., Davenport, M., & Khoury, D. (2022). In medRxiv.
Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19
Schilling, W., Jittamala, P., Watson, J., Ekkapongpisit, M., Siripoon, T., Ngamprasertchai, T., Luvira, V., Pongwilai, S., Cruz, C., Callery, J., Boyd, S., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Abdad, M., Piaraksa, N., Suwannasin, K., Hanboonkunupakarn, P., Hanboonkunupakarn, B., … White, N. (2022). In medRxiv.